I guess you fell for it. Let's see, first it needs to be re-engineered, then MCET needs to raise $5 million in equity funding. MCET has already gotten two extensions on the non-performance clause, have done nothing. My guess is that if big Pharma wanted the stent it could be had for $50K, basically what MCET paid for it. I wonder if the check bounced?